CCL Products (India) (CCL) Q3 25/26 earnings summary

Executive summary

• Achieved Q3 turnover of INR 1,053 crore, up 38% year-over-year; nine-month turnover at INR 3,239.41 crore, up 42% year-over-year.

• Q3 net profit at INR 100.26 crore, up 59% year-over-year; nine-month net profit at INR 273.57 crore, up 31% year-over-year.

• Un-audited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025, were approved and reviewed by statutory auditors with unmodified reports.

• Domestic branded sales for nine months at INR 330 crore, with strong growth momentum and expanding distribution.

• Interim dividend of INR 2.75 per equity share declared for FY 2025-26, with record date set for February 10, 2026.

Financial highlights

• Consolidated Q3 revenue from operations: Rs. 1,05,056.46 lakhs; nine months: Rs. 3,23,292.96 lakhs.

• Consolidated Q3 net profit: Rs. 10,026.78 lakhs; nine months: Rs. 27,357.38 lakhs.

• Q3 EBITDA at INR 187.56 crore, up 47% year-over-year; nine-month EBITDA at INR 547.6 crore, up 38%.

• Q3 PBT at INR 116.27 crore, up 62% year-over-year; nine-month PBT at INR 337.55 crore, up 37%.

• EBITDA per kg improved to INR 135-140, with guidance to maintain these levels.

Outlook and guidance

• Volume growth guidance remains at 18%-20% for FY26; EBITDA growth guidance revised to ~25% for FY26.

• Long-term EBITDA growth guidance of 15%-20% remains intact, pending further clarity on coffee prices.

• Capacity utilization expected to reach 80%-85% in two years, with future expansion plans to be considered then.

• Management continues to monitor regulatory changes, especially new Labour Codes, and has made provisions for potential impacts.